DENTSPLY SIRONA Inc (XRAY) Stake Lifted by Schroder Investment Management Group

Schroder Investment Management Group grew its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 53.9% during the third quarter, HoldingsChannel.com reports. The firm owned 2,767,132 shares of the medical instruments supplier’s stock after acquiring an additional 969,409 shares during the quarter. Schroder Investment Management Group’s holdings in DENTSPLY SIRONA were worth $104,432,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in XRAY. Piedmont Investment Advisors LLC bought a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $117,000. Qube Research & Technologies Ltd bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $134,000. NuWave Investment Management LLC increased its holdings in DENTSPLY SIRONA by 22,360.0% during the 3rd quarter. NuWave Investment Management LLC now owns 3,369 shares of the medical instruments supplier’s stock worth $127,000 after purchasing an additional 3,354 shares in the last quarter. Rockefeller Capital Management L.P. increased its holdings in DENTSPLY SIRONA by 1,941.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 3,369 shares of the medical instruments supplier’s stock worth $127,000 after purchasing an additional 3,204 shares in the last quarter. Finally, Exane Asset Management increased its holdings in DENTSPLY SIRONA by 41.3% during the 2nd quarter. Exane Asset Management now owns 4,678 shares of the medical instruments supplier’s stock worth $205,000 after purchasing an additional 1,368 shares in the last quarter. 99.39% of the stock is currently owned by institutional investors.

A number of analysts have commented on the company. HC Wainwright set a $40.00 price objective on DENTSPLY SIRONA and gave the stock a “hold” rating in a report on Friday, August 31st. ValuEngine raised DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 24th. Robert W. Baird lowered DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and decreased their price objective for the stock from $56.00 to $38.00 in a report on Tuesday, August 7th. BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday. Finally, Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating for the company in a report on Wednesday, August 8th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have assigned a buy rating to the company’s stock. DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $51.50.

Shares of XRAY opened at $36.51 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.76 and a quick ratio of 1.14. The company has a market cap of $8.13 billion, a price-to-earnings ratio of 13.73, a P/E/G ratio of 2.22 and a beta of 1.15. DENTSPLY SIRONA Inc has a 52 week low of $33.93 and a 52 week high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.46 by ($0.08). The business had revenue of $928.40 million during the quarter, compared to the consensus estimate of $951.58 million. DENTSPLY SIRONA had a negative net margin of 41.97% and a positive return on equity of 8.68%. The business’s revenue was down 8.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.70 earnings per share. Analysts expect that DENTSPLY SIRONA Inc will post 1.97 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This article was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.wkrb13.com/2018/11/25/dentsply-sirona-inc-xray-stake-lifted-by-schroder-investment-management-group.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: Investing strategies using the yield curve

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply